Therapeutic Options in High-risk Non-muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guerin

被引：61
|
作者：
Mostafid, A. Hugh [1 ]
Palou Redorta, Joan [2 ]
Sylvester, Richard [3 ]
Witjes, J. Alfred [4 ]
机构：
[1] Royal Surrey Cty Hosp, Dept Urol, Guildford, Surrey, England
[2] Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, E-08193 Barcelona, Spain
[3] European Org Res Treatment Canc, Brussels, Belgium
[4] Radboud UMC, Dept Urol, Nijmegen, Netherlands
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 03期
关键词：
TRANSITIONAL-CELL CARCINOMA; IMMUNOTHERAPY; MAINTENANCE; T1; TA;
D O I：
10.1016/j.eururo.2014.11.031
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 360
页数：2
相关论文
共 50 条
  • [21] TREATMENT PATTERNS IN HIGH-RISK, BACILLE CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW
    Broughton, E.
    Chun, D.
    Gooden, K.
    Hofer, K.
    Fazeli, M. S.
    VALUE IN HEALTH, 2020, 23 : S64 - S64
  • [22] Maintenance Bacillus Calmette-Guerin: The Standard of Care for the Prophylaxis and Management of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer
    Lamm, Donald
    Persad, Raj
    Colombel, Marc
    Brausi, Maurizio
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (09) : 715 - 734
  • [23] Comparative study between mitomycin C versus Bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer
    Zaza, Mohamed Mahmoud Abdelfatah
    Salem, Tarek Abd El-Mageed
    El-Sadat, Ahmed Mohamed
    Ali, Mohammed Hassan
    UROLOGIA JOURNAL, 2024, 91 (01) : 61 - 68
  • [24] Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
    Lenfant, Louis
    Seisen, Thomas
    Loriot, Yohann
    Roupret, Morgan
    EUROPEAN UROLOGY, 2020, 78 (01) : 1 - 3
  • [25] Assessment of Lower Urinary Tract Symptoms after Bacille Calmette-Guerin Instillation Therapy for Non-Muscle-Invasive Bladder Cancer
    Yoshio, S.
    Yoshimura, K.
    Matsui, Y.
    Imamura, M.
    Shimizu, Y.
    Inoue, T.
    Okubo, K.
    Kamba, T.
    Nishiyama, H.
    Ogawa, O.
    UROLOGY, 2012, 80 (03) : S221 - S221
  • [26] Combination of Intravesical Bacille Calmette-Guerin and Chemotherapy vs. Bacille Calmette-Guerin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
    Huang, Di
    Jin, Ying-Hui
    Weng, Hong
    Huang, Qiao
    Zeng, Xian-Tao
    Wang, Xing-Huan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [27] The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
    Krajewski, Wojciech
    Zdrojowy, Romuald
    Dembowski, Janusz
    Poletajew, Slawomir
    Wrobel, Michal
    Luczak, Mateusz
    Tukiendorf, Andrzej
    Kolodziej, Anna
    UROLOGIA INTERNATIONALIS, 2019, 102 (01) : 60 - 68
  • [28] Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
    McElree, Ian M.
    Steinberg, Ryan L.
    Mott, Sarah L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JAMA NETWORK OPEN, 2023, 6 (02) : e230849
  • [29] Replacement Instead of Discontinuation of Bacillus Calmette-Guerin Instillation in Non-Muscle-Invasive Bladder Cancer
    Lin, Po-Ting
    Hung, Wei-Kang
    Chang, Ying-Hsu
    Hsieh, Ming-Li
    Liu, Chung-Yi
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Lin, Po-Hung
    Yu, Kai-Jie
    Chuang, Cheng-Keng
    Wu, Chun-Te
    Pang, See-Tong
    Shao, I-Hung
    CANCERS, 2023, 15 (04)
  • [30] Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
    Su, Fei
    Liu, Ming
    Zhang, Wei
    Tang, Min
    Zhang, Jinsong
    Li, Hexin
    Zou, Lihui
    Zhang, Rui
    Liu, Yudong
    Li, Lin
    Ma, Jie
    Zhang, Yaqun
    Chen, Meng
    Xiao, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
12345